跳至主要内容
临床试验/NCT00827736
NCT00827736已完成4 期

Botulin Toxin Versus Isosorbidedinitrate Ointment in Treatment Anal Fissure; A Prospective, Blinded, Randomized Trial

Onze Lieve Vrouwe Gasthuis1 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2002年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
73
试验地点
1
主要终点
macroscopic healing of the fissure

研究概览

简要总结

The standard treatment of anal fissure in the netherlands (ISDN ointment) is being compared to a relatively new treatment (injection of Botox in the internal anal sphincter). The study hypothesis is that after 4 months, Botox has healed more patients than ISDN. The comparison is done blinded for the surgeon and the patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all consecutive patients over the age of 18 with a chronic anal fissure presenting to our surgical outpatient clinic

排除标准

  • pregnancy
  • previous anal surgery
  • Crohn's disease
  • systemic causes of an anal fissure

研究组 & 干预措施

Botox injection

Experimental

injection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline. In addition, a placebo ointment has to be applied to the anoderm six times a day

干预措施: Botox (Procedure)

ISDN ointment

Active Comparator

application of ISDN 1% ointment 6 times a day. injection of placebo into internal anal sphincter

干预措施: Botox (Procedure)

ISDN ointment

Active Comparator

application of ISDN 1% ointment 6 times a day. injection of placebo into internal anal sphincter

干预措施: ISDN ointment (Drug)

ISDN ointment

Active Comparator

application of ISDN 1% ointment 6 times a day. injection of placebo into internal anal sphincter

干预措施: Placebo (Drug)

结局指标

主要结局

macroscopic healing of the fissure

时间窗: 4 months

次要结局

  • complications(12 months)
  • fissure recurrence(12 months)
  • fissure related pain(12 months)
  • costs(12 months)

研究者

发起方
Onze Lieve Vrouwe Gasthuis
申办方类型
Other

研究点 (1)

Loading locations...

相似试验